Target intelligence / Profile preview

Poly(rC)-binding protein 2 mRNA (PCBP2 mRNA)

Target
PCBP2 mRNA
Molecular classification
Messenger RNA
01

Overview

Poly(rC)-binding protein 2 (PCBP2) mRNA encodes a multifunctional RNA-binding protein that plays a critical role in post-transcriptional regulation, including mRNA stabilization and translational control (UniProt Q15366). In the context of fibrotic diseases, PCBP2 is known to stabilize the mRNA of Type I collagen, thereby promoting the excessive deposition of extracellular matrix in organs like the liver and pancreas (PMID: 23536554). Therapeutic strategies targeting PCBP2 mRNA utilize small interfering RNA (siRNA) to induce its degradation, effectively reducing the production of the PCBP2 protein and subsequently decreasing collagen synthesis. A prominent example is BMS-986263 (formerly ND-L02-s0201), a vitamin A-coupled lipid nanoparticle carrying siRNA, which specifically targets activated hepatic stellate cells to treat liver fibrosis (PMID: 28811273). Beyond fibrosis, PCBP2 is involved in the life cycle of various RNA viruses, such as Poliovirus and Hepatitis C, by binding to internal ribosome entry sites (IRES) to facilitate viral translation. Consequently, PCBP2 mRNA represents a high-value target for RNA-based therapeutics aiming to modulate protein expression in chronic inflammatory and fibrotic conditions.

Other names
HNRNPX mRNAhnRNP E2 mRNAalpha-CP2 mRNAPoly(rC)-binding protein 2 messenger RNA
02

Mechanism of action

RNA interference (siRNA-mediated degradation of PCBP2 mRNA to reduce protein expression)

03

Biological functions

mRNA stability regulationTranslational controlRNA processingViral internal ribosome entry site (IRES) binding
04

Disease associations

Liver fibrosisPancreatic fibrosisHepatocellular carcinomaViral infection (e.g., Poliovirus, Hepatitis C)
05

Safety considerations

Potential off-target effects of siRNALipid nanoparticle (LNP) delivery vehicle toxicitySystemic knockdown effects due to ubiquitous PCBP2 expressionImmunogenicity of the delivery system
06

Interacting drugs

BMS-986263 (ND-L02-s0201)
07

Biomarkers

PCBP2 protein levelsCollagen Type I expressionAlpha-smooth muscle actin (α-SMA) levelsLiver stiffness (FibroScan)

Beyond the preview

Go deeper on Poly(rC)-binding protein 2 mRNA (PCBP2 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly(rC)-binding protein 2 mRNA (PCBP2 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call